Abstract
Heart failure is a leading cause of death in developed nations despite medical management. The prevalence of heart failure in Europe is 0.3 – 2%, and it affects approximately 10 million people living in nations represented by the European Society of Cardiology. Although advanced age is considered a relative contraindication to heart transplantation, there is no published consensus – on critical age in the case of mechanical circulatory support (MCS). The financial impact of destination MCS therapy in elderly heart failure patients is another important aspect for discussion with the medical community, hospital providers, insurance companies, and society at large.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
